BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Recs

0
Player Avatar zaktaylor33 (< 20) Submitted: 11/13/2009 1:23:32 PM : Outperform Start Price: $12.24 BCRX Score: -93.53

following tmf on this one

Featured Broker Partners


Advertisement